The current study shows that GPX4 in tumor cells regulates the ubiquitination and expression of the lesser-studied enzyme KYNU in the kynurenine pathway by controlling intracellular ROS levels, affecting kynurenine levels in the TME and ultimately affecting macrophage polarization. Here, KYNU is linked to neoplasm.